Aya M. Azawi-Al
Al Ain, AZ, United Arab Emirates
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Pharmacological inhibition of CBP sensitizes breast cancer to DNA-damaging agents by compromising DNA repair and cell cycle pathways.
Journal: Translational research : the journal of laboratory and clinical medicine
Published: June 11, 2026
β-Hydroxybutyrate Inhibits Angiogenesis, Suppresses Non-Small Cell Lung Cancer Growth, and Enhances Gemcitabine Antitumor Activity.
Journal: International journal of molecular sciences
Published: April 21, 2026
The PCNA inhibitor AOH1996 impairs tumor growth and invasiveness in non-small cell lung cancer.
Journal: Frontiers in pharmacology
Published: February 02, 2026
Geophytochemical and ethnopharmacological insights into Calotropis procera: bridging traditional knowledge and modern therapeutics.
Journal: Natural product research
Published: September 03, 2025
Exploring the Anticancer Potential of Origanum majorana Essential Oil Monoterpenes Alone and in Combination against Non-Small Cell Lung Cancer.
Journal: Nutrients
Published: October 09, 2023
PD-1 Independent Role of PD-L1 in Triple-Negative Breast Cancer Progression.
Journal: International journal of molecular sciences
Published: December 08, 2022
Origanum majorana essential oil decreases lung tumor growth and metastasis in vitro and in vivo.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 12, 2022
Butein and Frondoside-A Combination Exhibits Additive Anti-Cancer Effects on Tumor Cell Viability, Colony Growth, and Invasion and Synergism on Endothelial Cell Migration.
Journal: International journal of molecular sciences
Published: December 01, 2021
Impact of Sodium Dichloroacetate Alone and in Combination Therapies on Lung Tumor Growth and Metastasis.
Journal: International journal of molecular sciences
Published: October 24, 2021
Role of flavonoids in thrombotic, cardiovascular, and inflammatory diseases.
Journal: Inflammopharmacology
Published: April 12, 2019
Inhibition of SHP2 by new compounds induces differential effects on RAS/RAF/ERK and PI3K/AKT pathways in different cancer cell types.
Journal: Investigational new drugs
Published: May 11, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026